Regulation of Eucalyptine Capsules as Dangerous Drugs

Ask AI

DDB BOARD REGULATION NO. 1: Regulation of Eucalyptine Capsules as Dangerous Drugs

Getting related questions...
What do you want to know about the law?
Your conversations and searches stay on your device. We do not store or track your activity on our servers. To know more about our privacy commitment see jur.ph/privacy Ask AI provides quick answers grounded in full case texts to avoid mistakes. Always verify with the original text.

Ask AI

Title Supreme Court: Regulation of Eucalyptine Capsules as Dangerous Drugs

Law: Ddb Board Regulation No. 1

Decision Date: Jan 7, 1975

EUCALYPTINE capsules containing 492 mg of codeine per 100 grams are classified as regulated drugs by the Dangerous Drugs Board, effective immediately, in accordance with Republic Act No. 6425.

regulated drugs

dangerous drugs

drug classification

A

Scope of Regulation and Inclusion Criteria

Eucalyptine capsules exceeding the limitations set forth in Board Regulation No. 1, series of 1973, are considered dangerous drugs.
This implies that any formulation of Eucalyptine capsules with codeine content beyond the established thresholds is subject to regulation.

Relationship to Previous Regulations

This regulation serves as a supplement to Board Regulation No. 6, series of 1972.
It expands the list of substances covered under existing drug regulations to include specified Eucalyptine capsules.

Legal Authority and Effectivity

The regulation was adopted on January 7, 1975, and took effect immediately upon issuance.
It was enacted under the signature of Clemente S. Gatmaitan, M.D., M.P.H., Chairman of the Dangerous Drugs Board.

Key Legal Concepts

The regulation emphasizes the control over substances containing codeine due to their potential misuse.
It reinforces the Dangerous Drugs Board's mandate to regulate drug preparations that pose health and legal risks under Republic Act No. 6425, as amended.

END